CL2007002862A1 - Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha. - Google Patents

Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha.

Info

Publication number: CL2007002862A1
Authority: CL; Chile
Prior art keywords: egf; ischemical; neuritis; manifestations; motor
Prior art date: 2006-10-03

Application number

CL200702862A

Other languages

English (en)

Inventor

Montequin Jose Ignac Fernandez

Original Assignee

Ct Ingenieria Genetica Biotech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-03

Filing date

2007-10-03

Publication date

2008-05-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38925545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007002862(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-10-03 Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech

2008-05-23 Publication of CL2007002862A1 publication Critical patent/CL2007002862A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

CL200702862A 2006-10-03 2007-10-03 Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha. CL2007002862A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CU20060192A CU23526B6 (es)	2006-10-03	2006-10-03	Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética

Publications (1)

Publication Number	Publication Date
CL2007002862A1 true CL2007002862A1 (es)	2008-05-23

Family

ID=38925545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200702862A CL2007002862A1 (es)	2006-10-03	2007-10-03	Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha.

Country Status (20)

Country	Link
US (2)	US8642552B2 (es)
EP (1)	EP2075004B1 (es)
JP (1)	JP5508853B2 (es)
KR (1)	KR101464208B1 (es)
CN (1)	CN101573130B (es)
AR (1)	AR063088A1 (es)
AT (1)	ATE544462T1 (es)
AU (1)	AU2007304640B2 (es)
BR (1)	BRPI0719816B8 (es)
CA (1)	CA2665117C (es)
CL (1)	CL2007002862A1 (es)
CU (1)	CU23526B6 (es)
DK (1)	DK2075004T3 (es)
ES (1)	ES2386058T3 (es)
MX (1)	MX2009003678A (es)
PL (1)	PL2075004T3 (es)
PT (1)	PT2075004E (es)
RU (1)	RU2460536C2 (es)
WO (1)	WO2008040260A1 (es)
ZA (1)	ZA200902311B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101252740B1 (ko) *	2011-05-25	2013-04-11	연세대학교 산학협력단	센서 및 센싱방법
EP2737895A1 (en) *	2012-11-30	2014-06-04	Praxis Pharmaceutical, S.A.	Microparticles with EGF, method of preparation and use
KR102228358B1 (ko) *	2012-12-21	2021-03-16	쉬케후세트 솔란데트 에이치에프	신경 장애 및 통증의 ｅｇｆｒ 표적 치료
US9387151B2 (en)	2013-08-20	2016-07-12	Anutra Medical, Inc.	Syringe fill system and method
IL312865B1 (en)	2013-09-11	2025-02-01	Eagle Biologics Inc	Liquid protein formulations containing viscosity-reducing agents
USD774182S1 (en)	2014-06-06	2016-12-13	Anutra Medical, Inc.	Anesthetic delivery device
USD750768S1 (en)	2014-06-06	2016-03-01	Anutra Medical, Inc.	Fluid administration syringe
USD763433S1 (en)	2014-06-06	2016-08-09	Anutra Medical, Inc.	Delivery system cassette
SG11201702614SA (en)	2014-10-01	2017-04-27	Eagle Biolog Inc	Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
RU2585421C1 (ru) *	2014-12-24	2016-05-27	Артур Владимирович Маргасов	Способ восстановления поврежденного нерва

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5130298A (en) *	1989-05-16	1992-07-14	Ethicon, Inc.	Stabilized compositions containing epidermal growth factor
SE9601243D0 (sv)	1996-03-29	1996-03-29	Hans Arne Hansson	Promotion of regeneration of organized tissues
AU2231399A (en)	1998-01-20	1999-08-02	Aurx, Inc.	A herpes virus vector
US6444205B2 (en)	1998-09-30	2002-09-03	Diacrin, Inc.	Transplantation of neural cells for the treatment of chronic pain or spasticity
SE9804064D0 (sv)	1998-11-25	1998-11-25	A & Science Invest Ab	Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
CA2365434A1 (en) *	1999-04-15	2000-10-26	St. Elizabeth's Medical Center Of Boston	Angiogenic growth factors for treatment of peripheral neuropathy
WO2002012335A2 (en)	2000-08-10	2002-02-14	Pharmacia Corporation	A NEW EGF MOTIF REPEAT PROTEIN OBTAINED FROM A cDNA LIBRARY FROM HS-5 STROMAL CELL LINE
CU23157A1 (es)	2001-01-03	2006-07-18	Ct Ingenieria Genetica Biotech	COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
JP2006152001A (ja)	2001-03-12	2006-06-15	Institute Of Gene & Brain Science	神経損傷の治療薬
JP3607271B2 (ja)	2001-03-12	2005-01-05	株式会社Ｇｂｓ研究所	神経損傷の治療薬
HK1077740A1 (en) *	2001-12-20	2006-02-24	Ct Ingenieria Genetica Biotech	Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
US7465463B2 (en)	2002-09-04	2008-12-16	Polyheal, Ltd.	Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
US20070122487A1 (en) *	2003-03-19	2007-05-31	University Of Kentucky Research Foundation	(Poly(acryloyl-hydroxyethyl starch)-plga composition microspheres
ES2354304T3 (es) *	2003-04-25	2011-03-11	The University Of Pittsburgh	Células derivadas del músculo (mdcs) para promover y potenciar la regeneración y reparación de nervios.
CN101090732A (zh)	2004-08-06	2007-12-19	谷柔派普有限公司	治疗糖尿病的方法
CN101150954A (zh) *	2005-01-21	2008-03-26	西北大学	包封细胞的方法和组合物
KR100765496B1 (ko)	2005-12-09	2007-10-10	경희대학교 산학협력단	히레귤린 베타1의 ｅｇｆ-성 도메인 펩타이드를 암호화하는ｄｎａ 서열을 포함하는 재조합 아데노바이러스 및 이를포함하는 신경세포 분화 및 재생용 약학 조성물

2006
- 2006-10-03 CU CU20060192A patent/CU23526B6/es active IP Right Grant
2007
- 2007-10-01 AT AT07817382T patent/ATE544462T1/de active
- 2007-10-01 JP JP2009530751A patent/JP5508853B2/ja active Active
- 2007-10-01 PL PL07817382T patent/PL2075004T3/pl unknown
- 2007-10-01 DK DK07817382.0T patent/DK2075004T3/da active
- 2007-10-01 AU AU2007304640A patent/AU2007304640B2/en not_active Ceased
- 2007-10-01 BR BRPI0719816A patent/BRPI0719816B8/pt not_active IP Right Cessation
- 2007-10-01 RU RU2009116646/15A patent/RU2460536C2/ru active
- 2007-10-01 PT PT07817382T patent/PT2075004E/pt unknown
- 2007-10-01 AR ARP070104350A patent/AR063088A1/es unknown
- 2007-10-01 ES ES07817382T patent/ES2386058T3/es active Active
- 2007-10-01 CN CN2007800422158A patent/CN101573130B/zh not_active Expired - Fee Related
- 2007-10-01 WO PCT/CU2007/000018 patent/WO2008040260A1/es active Application Filing
- 2007-10-01 EP EP07817382A patent/EP2075004B1/en not_active Not-in-force
- 2007-10-01 MX MX2009003678A patent/MX2009003678A/es active IP Right Grant
- 2007-10-01 US US12/443,837 patent/US8642552B2/en active Active
- 2007-10-01 CA CA2665117A patent/CA2665117C/en not_active Expired - Fee Related
- 2007-10-01 KR KR1020097009188A patent/KR101464208B1/ko not_active Expired - Fee Related
- 2007-10-03 CL CL200702862A patent/CL2007002862A1/es unknown
2009
- 2009-04-02 ZA ZA200902311A patent/ZA200902311B/xx unknown
2013
- 2013-12-26 US US14/140,849 patent/US9034826B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20100136062A1 (en)	2010-06-03
JP5508853B2 (ja)	2014-06-04
AU2007304640A1 (en)	2008-04-10
US9034826B2 (en)	2015-05-19
EP2075004B1 (en)	2012-02-08
CN101573130A (zh)	2009-11-04
US20140105990A1 (en)	2014-04-17
WO2008040260A1 (es)	2008-04-10
ZA200902311B (en)	2010-04-28
KR101464208B1 (ko)	2014-12-04
RU2460536C2 (ru)	2012-09-10
US8642552B2 (en)	2014-02-04
KR20090103862A (ko)	2009-10-01
ATE544462T1 (de)	2012-02-15
PT2075004E (pt)	2012-05-02
DK2075004T3 (da)	2012-05-14
ES2386058T3 (es)	2012-08-08
BRPI0719816B8 (pt)	2021-05-25
RU2009116646A (ru)	2010-11-10
PL2075004T3 (pl)	2012-09-28
AU2007304640B2 (en)	2013-01-17
AR063088A1 (es)	2008-12-23
EP2075004A1 (en)	2009-07-01
MX2009003678A (es)	2009-04-22
CA2665117C (en)	2015-04-14
BRPI0719816B1 (pt)	2018-04-24
BRPI0719816A2 (pt)	2015-09-08
CU23526B6 (es)	2010-05-19
JP2010505773A (ja)	2010-02-25
CN101573130B (zh)	2012-10-31
CA2665117A1 (en)	2008-04-10

Similar Documents

Publication	Publication Date	Title
CL2007002862A1 (es)	2008-05-23	Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha.
DOP2010000304A (es)	2011-10-15	Composiciones y metodos de preparacion y uso de las mismas
CL2007002635A1 (es)	2009-10-23	Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion.
CL2013003372A1 (es)	2014-07-25	Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
CO6280490A2 (es)	2011-05-20	4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
CL2007002188A1 (es)	2008-02-01	Compuestos derivados de heteroarilaminas; procedimiento de preparacion; composicion farmceutica; y uso del compuesto para tratar el crecimiento celular anormal.
GT201400111A (es)	2015-11-30	Triazolopiridinas sustituidas
CL2007002971A1 (es)	2008-05-30	Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CL2009000349A1 (es)	2010-02-19	Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
UY33597A (es)	2012-04-30	Compuestos y composiciones como inhibidores de la trk
CL2012002189A1 (es)	2012-11-23	Compuestos derivados de pirrolidina-2-carboxamidas sustituidas; inhibidores de la interaccion mdm2-p53; composicion farmaceutica; y su uso para el tratamiento del cancer, en particular de tumores solidos.
CL2011002787A1 (es)	2012-06-22	Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica.
CR11802A (es)	2011-01-12	Derivados de indazoles sustituidos con fenilo o piridinilo
DOP2011000176A (es)	2011-10-31	Compuestos organicos
CL2013001295A1 (es)	2013-10-04	Compuestos derivados de 2,3-dihidromidazo (1,2-c) quinazolina sustituidos con aminoalcoholes; compuesto intermediario y su uso; composicion farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis.
EA033311B1 (ru)	2019-09-30	Производные бензоксаборола в качестве антибактериальных средств
MX2012007098A (es)	2012-07-20	Derivados fenolicos y su uso farmaceutico o cosmetico.
CL2008002430A1 (es)	2009-10-16	Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
DOP2016000253A (es)	2016-10-31	Nuevos compuestos
ECSP13012573A (es)	2013-07-31	6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
ECSP099616A (es)	2009-10-30	Estabilización de vitamina b12
CO6300844A2 (es)	2011-07-21	Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
CL2007002970A1 (es)	2008-05-30	Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
BR112018002983A2 (pt)	2018-09-25	composição compreendendo uma lactama e um álcool
CL2008002726A1 (es)	2008-10-10	Compuestos derivados de isoquinolinilo e isoindolinilo, antagonistas de histamina-3; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos del sistema nervioso c